Correlation Between GlaxoSmithKline PLC and Compagnie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Compagnie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Compagnie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Compagnie du Bois, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Compagnie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Compagnie. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Compagnie.

Diversification Opportunities for GlaxoSmithKline PLC and Compagnie

0.95
  Correlation Coefficient

Almost no diversification

The 3 months correlation between GlaxoSmithKline and Compagnie is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Compagnie du Bois in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compagnie du Bois and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Compagnie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compagnie du Bois has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Compagnie go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Compagnie

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.91 times more return on investment than Compagnie. However, GlaxoSmithKline PLC ADR is 1.1 times less risky than Compagnie. It trades about 0.01 of its potential returns per unit of risk. Compagnie du Bois is currently generating about -0.04 per unit of risk. If you would invest  3,410  in GlaxoSmithKline PLC ADR on August 28, 2024 and sell it today you would lose (8.00) from holding GlaxoSmithKline PLC ADR or give up 0.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy98.22%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Compagnie du Bois

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Compagnie du Bois 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compagnie du Bois has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

GlaxoSmithKline PLC and Compagnie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Compagnie

The main advantage of trading using opposite GlaxoSmithKline PLC and Compagnie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Compagnie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compagnie will offset losses from the drop in Compagnie's long position.
The idea behind GlaxoSmithKline PLC ADR and Compagnie du Bois pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories